Ignite Creation Date:
2025-12-24 @ 3:30 PM
Ignite Modification Date:
2026-02-02 @ 1:45 PM
Study NCT ID:
NCT07089992
Status:
RECRUITING
Last Update Posted:
2025-12-16
First Post:
2025-07-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Pembrolizumab in People With Ultra-Rare Sarcomas
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Sarcoma | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Pleomorphic liposarcoma | View |
| None | PEComa (perivascular epithelial cell tumor) | View |
| None | Epithelioid sarcoma | View |
| None | CIC-rearranged sarcoma | View |
| None | SEF/LGFMS: Sclerosing epithelioid fibrosarcoma - low grade fibromyxoid sarcoma | View |
| None | Ultra-Rare Sarcomas | View |
| None | Pembrolizumab | View |
| None | 25-165 | View |